Pavel Alexeevich Drozdov

Pavel Alexeevich Drozdov

Auto-generated profile, based on publicly available information

Pavel Alexeevich Drozdov

Botkin Hospital

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2022 in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
Verified
Journal Article
Open access
PDF file
ASA. V. Shabunin
A. V. Shabunin
VBV. V. Bedin
V. V. Bedin
PDP. A. Drozdov
P. A. Drozdov
OLO. N. Levina
O. N. Levina
VTV. A. Tsurkan
V. A. Tsurkan
OZO. S. Zhuravel
O. S. Zhuravel
Aim: Analysis of the first experience of transjugular intrahepatic portosystemic shunting (TIPS) in patients with liver cirrhosis at a multidisciplinary hospital with a liver transplantation program.Materials and methods: The authors examined 206 patients with liver cirrhosis from July 2019 to June 2021, with 20 of them undergoing TIPS. The mean age of the patients was 47.59 ± 9.55 years (35–65 years). Dynamic follow-up was performed at 3, 6, 9, 12, and 18 months. As a part of the dynamic follow-up, the patients underwent laboratory tests, abdomen ultrasound examination, and computed tomography imaging enhanced by the intravenous use of contrasting agent, endoscopy, esophagogastroduodenoscopy, and encephalopathy assessment.Results: No in-hospital TIPS-associated mortality has been reported. Two patients died in the hospital at the 19th and 26th day following the surgery because of the progression of liver failure, the 6-week mortality rate was 10%. In one patient (5%), an intraoperative complication was reported, i.e., intra-abdominal hemorrhage secondary to the migration of the stent under the liver capsule. The length of hospital stay after surgery was 7.34 ± 1.89 days (5–26 days). Long-term outcomes were available for 17 patients. The duration of the dynamic follow-up was 13.23 ± 2.47 months (3–24 months) and 2 (11,7%) deaths were reported. One patient (5.8%) was diagnosed with a shunt thrombosis at 12 months after the surgery. Three patients underwent liver transplantation after TIPS. The current one-year survival rate is 90%.Conclusion: TIPS is a safe and effective procedure decreasing mortality and improving quality of life of patients awaiting cadaveric liver transplantation. TIPS should be widely implemented in multidisciplinary hospitals having liver transplant program.

14 September 2022 in Transplantologiya. The Russian Journal of Transplantation
Verified
Journal Article
Open access
PDF file
ASA. V. Shabunin
A. V. Shabunin
PDP. A. Drozdov
P. A. Drozdov
INI. V. Nesterenko
I. V. Nesterenko
DMD. A. Makeev
D. A. Makeev
OZO. S. Zhuravel
O. S. Zhuravel
SAS. A. Astapovich
S. A. Astapovich
Aim. To determine statistically significant risk factors for delayed renal graft function. To assess the impact of delayed kidney graft function on the development of other complications, graft and recipient survival.Material and methods. In 237 consecutive kidney transplant recipients (from June 2018 to December 2021), we assessed its function in the early postoperative period. Delayed function was considered to be the need for hemodialysis in the first week after surgery. Among the donor factors, the type of donor, age, body mass index, the presence of vasopressor support, the time the donor was in intensive care, and the maximum level of creatinine during the follow-up were evaluated. Recipient risk factors include age, gender, body mass index, presence/absence and amount of urine, presence of preformed anti-HLA antibodies and/or repeated kidney transplantation, number of mismatches for six HLA antigens, number of mismatches for HLA-DR, presence and type of renal replacement therapy, etiology of end stage kidney disease. Among the perioperative risk factors are the duration of cold preservation, the time of second warm ischemia, the volume of intraoperative blood loss, the intraoperatively determined renal arterial resistive index of the renal graft, and the maximum concentration of tacrolimus in the first 4 days after kidney transplantation. After that the relationship between the presence of delayed kidney graft function and the development of early postoperative complications was assessed and its effect on the long-term survival of grafts and recipients was analyzed.Results. Out of 237 cases, 9 showed no function of the transplanted kidney, and therefore the grafts were removed. The incidence of delayed renal graft function was 24.5% (58/237). According to the results of a univariate analysis, a statistically significant relationship with the development of delayed kidney graft function had donor body mass index (p=0.019), male gender of the recipient (p=0.048), recipient body mass index (p=0.038), amount of urine (p=0.003), anuria (p=0.002), presence of preformed antibodies (p=0.025), repeated transplantation (p=0.002), time of second warm ischemia (p=0.036), intraoperative renal arterial resistive index (p=0.004) and maximum tacrolimus concentration in the first 4 days (p=0.022). In the multivariate model, donor body mass index >30 kg/m2 and peak tacrolimus concentration >23 ng/mL in the first 4 days were statistically significant (p=0.018 and p=0.025, respectively). A trend towards statistical significance was noted in the presence of oligoanuria before kidney transplantation (p=0.066) and resistance index >0.75 after surgery (p=0.056). One-year renal transplant survival in the absence and presence of delayed kidney graft function was 92.4% and 87.7%, two-year survival was 89.4% and 76.1%, respectively. The effect of delayed kidney graft function on graft survival was statistically significant (p=0.01), while overall recipient survival did not differ between the groups.Conclusion. During the univariate analysis, we identified 9 statistically significant factors, of which at least 3 are potentially modifiable. In the multivariate model, the most significant modifiable risk factor was an increased concentration of tacrolimus, which prompted the authors to reconsider the existing immunosuppressive protocol at the City Clinical Hospital n.a. S.P. Botkin. We consider the search for modifiable statistically significant risk factors for patients, their analysis and implementation of preventive measures to be an important task for each kidney transplant center.

20 September 2022 in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
Verified
Journal Article
Open access
PDF file
ASA. V. Shabunin
A. V. Shabunin
VBV. V. Bedin
V. V. Bedin
DGD. N. Grekov
D. N. Grekov
MTM. M. Tavobilov
M. M. Tavobilov
PDP. A. Drozdov
P. A. Drozdov
VTV. A. Tsurkan
V. A. Tsurkan
Aim. To analyze the results of a multidisciplinary approach to the treatment of patients with hepatocellular cancer in a multidisciplinary oncology clinic.Materials and Methods. From 2007 to 2021, 259 patients with hepatocellular cancer were surgically treated in the Department of Liver and Pancreas Surgery of the city clinical hospital named after S.P. Botkin. Liver resections of different extent were performed in 74 (28.6%) patients, radiofrequency ablation – in 19 (7.3%), microwave ablation – in 20 (7.7%), hepatic artery chemoembolization with radiofrequency ablation – in 34 (13.1%), regional chemotherapy – in 104 (40.2%), liver transplantation – in 8 (3.1%) patients.Results. The overall five- and ten-year survival after liver resection was 51.4% and 31.1% respectively. The poor prognostic factors following liver resection were age >70 years (p = 0.03), postoperative complications (p = 0.04), lymph node metastases (p = 0.01), and a body mass index >30 kg/m2 (p = 0.045). Complications that developed after radiofrequency (microwave) ablation and chemoembolization of the hepatic artery with radiofrequency ablation were 5.1% and 5.8%. Within 90 days after liver resection, three (1.1%) patients died. Complications after resection developed in 18 (24.3%) cases during the same period. With metastases measuring ≤3 cm, the overall five-year survival after radiofrequency and microwave ablation was 36.8% and 35% respectively. With neoplasms measuring 3–5 cm, the best five-year survival was after hepatic artery chemoembolization and radiofrequency ablation (44.1%). The overall fiveyear survival after hepatic artery chemoembolization was 11.5%. No complications or deaths resulted from liver transplantation. With an average follow-up period of 12.5 months, none of the patients experienced disease recurrence or died.Conclusion. Using a multidisciplinary approach in a multidisciplinary oncology clinic improves the results of treating patients with hepatocellular cancer.

23 April 2020 in Russian Journal of Transplantology and Artificial Organs
Verified
Journal Article
Open access
PDF file
ASA. V. Shabunin
A. V. Shabunin
IPI. P. Parfenov
I. P. Parfenov
MMM. G. Minina
M. G. Minina
PDP. A. Drozdov
P. A. Drozdov
INI. V. Nesterenko
I. V. Nesterenko
OZO. S. Zhuravel
O. S. Zhuravel
Цель: оценить первые результаты программы трансплантации Боткинской больницы. Материалы и методы. С июня 2018-го по октябрь 2019 года в ГКБ им. С.П. Боткина выполнено 100 трансплантаций солидных органов. Из них 72 трансплантации почки: средний возраст реципиентов составил 45,65 ± 11,35 года, совпадение по HLA в среднем составило 2,09 ± 1,03 и 28 трансплантаций печени. Средний возраст реципиентов составил 50,14 ± 7,62 года, средний MELD составил 17,78 ± 3,28 (14–34). Результаты. После трансплантации органов 30-дневной летальности не зафиксировано. Послеоперационные осложнения после трансплантации почки зафиксированы у 11 больных (15,2%): у 3 (4,3%) – нагноение послеоперационной раны, у 2 (2,8%) – гематомы в зоне послеоперационного шва на фоне проведения гемодиализа, у 5 (6,9%) – лимфоцеле забрюшинного пространства, у 1 больного (1,4%) – уросепсис. Зафиксировано 4 случая (5,5%) острого отторжения, в 3 случаях (4,2%) – гуморальное отторжение, в 1 случае (1,3%) – клеточное. Ранние послеоперационные осложнения после трансплантации печени зафиксированы у 2 больных (7,2%): у одного больного – гематома под правой долей печени на 1-е сутки после операции, источником кровотечения явилась диафрагма, у одной больной – подтекание асцита через послеоперационные швы, что потребовало релапаротомии. У 2 больных (7,2%) зафиксированы послеоперационные осложнения в отдаленном послеоперационном периоде. В одном случае стриктура холедохо-холедохоанастомоза – выполнено стентирование стриктуры покрытым нитиноловым стентом. В другом случае острая спаечная кишечная непроходимость, что потребовало лапаротомии, адгезиолизиса. Заключение. Внедрение программы трансплантации в многопрофильные стационары позволяет увеличить объемы трансплантологической помощи в отдельно взятом регионе, улучшить результаты лечения больных с терминальным поражением органов.

15 January 2024 in Russian Journal of Transplantology and Artificial Organs
Verified
Journal Article
Open access
PDF file
ASA. V. Shabunin
A. V. Shabunin
PDP. A. Drozdov
P. A. Drozdov
INI. V. Nesterenko
I. V. Nesterenko
DMD. A. Makeev
D. A. Makeev
SAS. A. Astapovich
S. A. Astapovich
LKL. R. Karapetyan
L. R. Karapetyan
Влияние начальной функции пересаженной почки на ближайшие и отдаленные результаты

15 July 2023 in Russian Journal of Transplantology and Artificial Organs
Verified
Journal Article
Open access
PDF file
ASA. V. Shabunin
A. V. Shabunin
OLO. B. Loran
O. B. Loran
DPD. Yu. Pushkar
D. Yu. Pushkar
EVE. I. Veliev
E. I. Veliev
MMM. G. Minina
M. G. Minina
LKL. R. Karapetyan
L. R. Karapetyan
Цель: определить эффективность и безопасность применения комплексного подхода к профилактике развития отсроченной функции почечного трансплантата. Материалы и методы. С июня 2018-го по декабрь 2022 года в Городской клинической больнице имени С.П. Боткина выполнено 478 трансплантаций почки от посмертного донора. В зависимости от применения комплексного подхода больные были разделены на две группы: I группу составили 128 больных, кому не применялся комплексный подход; во II группу наблюдения были включены 67 больных, кому на периоперационном этапе применялся комплексный подход к профилактике развития отсроченной функции почечного трансплантата. Комплексный подход заключался в применении машинной оксигенированной холодовой перфузии при использовании доноров с расширенными критериями, применении устройства для элиминации вторичной тепловой ишемии, персонализированном подходе к назначению стартовой дозы ингибитора кальциневрина, применении алпростадила при высоком сосудистом сопротивлении в артериях почечного трансплантата. Результаты. Отсроченная функция почечного трансплантата при использовании комплексного подхода к ее профилактике развилась в 5 из 44 наблюдений (11,4%), в контрольной группе – у 13 из 44 пациентов (29,5%). Различия были статистически значимыми (р = 0,034), и между признаками была отмечена связь средней силы (V = 0,225). Использование комплексного профилактического подхода уменьшало шансы развития ОФПТ в 0,3 раза (95% ДИ: 0,1–0,95). Риск ОФПТ при использовании комплексного подхода составил 61,3% от риска развития отсроченной функции при отсутствии ее профилактики, таким образом, ОР = 1,63 (95% ДИ: 1,1–2,4). Медиана длительности нормализации функции трансплантата была статистически значимо ниже во II группе: 5 (IQR: 3–9) против 15 (IQR: 7–19) суток (р = 0,012). Средняя длительность госпитализации в I группе составила 19,1 ± 4,2 (95% ДИ: 14,5–26,1) койко-дня, во II – 13,9 ± 3,4 (95% ДИ: 9,3–17,2) койко-дня. Различия по данному показателю были также статистически значимыми (р = 0,043). Заключение. Разработанный в Боткинской больнице научно-обоснованный и внедренный в клиническую практику комплекс профилактических мер отсроченной функции почечного трансплантата позволяет существенно снизить бремя модифицируемых факторов риска данного осложнения и тем самым значимо улучшить результаты лечения реципиентов почечного трансплантата.